JAWS and the 2020 Hall of Fame Ballot: Jason Giambi
The following article is part of Jay Jaffe’s ongoing look at the candidates on the BBWAA 2020 Hall of Fame ballot. For a detailed introduction to this year’s ballot, and other candidates in the series, use the tool above; an introduction to JAWS can be found here. For a tentative schedule and a chance to fill out a Hall of Fame ballot for our crowdsourcing project, see here. All WAR figures refer to the Baseball-Reference version unless otherwise indicated.
No less an authority than Sports Illustrated anointed Jason Giambi “The New Face of Baseball” on the cover of its July 17, 2000 edition. At a time when balls were soaring over fences in record numbers, the wet, hulking slugger with his bulging biceps and flaming skull tattoo was midway through a season in which he would hit 43 homers while batting .333/.476/.647. His performance not only garnered him the AL MVP award, it helped the upstart A’s win the AL West.
Having gone through lean times since their 1988-92 heyday, the small-market A’s had returned to contention thanks to their resourcefulness and their signature belief in plate discipline. Giambi, a protégé of Mark McGwire who was blessed with extraordinary eyesight and a cerebral approach that belied his hard-partying persona, was just about the the most disciplined hitter in the game, at least this side of Barry Bonds. In 2000, his 137 walks, .476 on-base percentage, and 187 OPS+ all led the AL. He would hit the trifecta again the next year, with league highs of 129 walks, a .477 on-base percentage, and a 199 OPS+ to go with his 38 homers.
Giambi would remain one of the game’s faces during less happy times as well. In early 2004, two years into his seven-year, $120 million contract with the Yankees, his name surfaced in connection to the Bay Area Laboratory Co-Operative, which stood accused of distributing PEDs to athletes in several sports. In grand jury testimony that had leaked, Giambi confessed to having injected human growth hormone and testosterone as well as using “the clear” and “the cream,” two undetectable “designer” steroids distributed by BALCO.
Since baseball did not yet have a testing and suspension regimen, Giambi was never punished, but he was cast as a villain for awhile. Unlike so many other high-profile players associated with PEDs, however, he managed to find a way back into the good graces of both fans and the industry after publicly admitting to having used the drugs. He made a non-specific apology in 2005 so as to avoid further legal hassles, but got more specific two years later. The Yankees tried to free themselves of his contract multiple times to no avail, and commissioner Bud Selig threatened to fine and suspend him if he did not speak with former senator George Mitchell for his investigation into the game’s drug problems. Those heavy-handed attempts to shame him instead turned him into something of an antihero. He became a fan favorite all over again in New York, then spent six more seasons bouncing from Oakland to Colorado to Cleveland as a respected clubhouse sage and quasi-coach, finally retiring at age 43 following the 2014 season.
Though he made five All-Star teams, won an MVP award, and hit 440 homers — reaching 20 homers 11 times, 30 homers five times, and 40 homers three times — Giambi doesn’t have strong qualifications for Cooperstown via either traditional or advanced statistics, though he’s not as far off as one might think. He fares much better via WAR and JAWS than this ballot’s other first base/designated hitter types, but that doesn’t mean he’s likely to get enough support even to remain on the ballot, or that he merits it. Note that as with Bonds and McGwire, I don’t see his PED usage as disqualifying, as it’s confined to the period before MLB and the players’ union implemented a testing program.
Player | Career WAR | Peak WAR | JAWS |
---|---|---|---|
Jason Giambi | 50.5 | 42.2 | 46.4 |
Avg. HOF 1B | 66.8 | 42.7 | 54.8 |
H | HR | AVG/OBP/SLG | OPS+ |
2,010 | 440 | .277/.399/.516 | 139 |